Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · IEX Real-Time Price · USD
0.793
-0.032 (-3.90%)
At close: May 17, 2024, 4:00 PM
0.800
+0.007 (0.90%)
After-hours: May 17, 2024, 6:57 PM EDT
Bolt Biotherapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for BOLT stock have an average target of 1.25, with a low estimate of 1.00 and a high estimate of 1.50. The average target predicts an increase of 57.65% from the current stock price of 0.79.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for BOLT stock from 5 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 1 | 1 | 1 | 0 | 0 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 2 | 2 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $3 → $1 | Buy → Hold | Downgrades | $3 → $1 | +26.12% | May 15, 2024 |
| Jones Trading | Jones Trading | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | May 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | May 15, 2024 |
| Stifel | Stifel | Strong Buy → Hold Downgrades $6 → $1.5 | Strong Buy → Hold | Downgrades | $6 → $1.5 | +89.18% | May 15, 2024 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | May 15, 2024 |
Financial Forecast
Revenue This Year
9.13M
from 7.88M
Increased by 15.93%
Revenue Next Year
5.82M
from 9.13M
Decreased by -36.28%
EPS This Year
-1.79
from -1.83
EPS Next Year
-1.18
from -1.79
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 13.2M | 11.7M | 157.5M | 21.0M | 99.7M |
| Avg | 9.1M | 5.8M | 55.0M | 11.6M | 54.2M |
| Low | 5.9M | n/a | n/a | 2.6M | 11.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 67.0% | 27.8% | 2,607.1% | -61.8% | 761.5% |
| Avg | 15.9% | -36.3% | 844.8% | -78.9% | 368.2% |
| Low | -25.3% | - | - | -95.2% | -4.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.48 | -0.26 | 0.16 | -1.91 | -1.12 |
| Avg | -1.79 | -1.18 | -0.86 | -1.86 | -1.09 |
| Low | -1.92 | -1.69 | -1.49 | -1.78 | -1.05 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.